Inactive Instrument

Dthera Sciences

Equities

DTHR

US2333623005

Advanced Medical Equipment & Technology

Dthera Sciences Reports Earnings Results for the Year Ended December 31, 2017

April 03, 2018 at 04:57 pm IST

Dthera Sciences reported earnings results for the year ended December 31, 2017. For the year, the company reported a net loss of $2,558,547. This compared a net loss of $1,194,804, during the year ended December 31, 2016.

Latest news about Dthera Sciences

Telememory Holding Corp acquired Dthera Sciences.	11/22/11	CI
Dthera Sciences Enters into an Exclusivity Agreement with Respect to the Company’S Lead Product, DTHR-ALZ	23/19/23	CI
Dthera Sciences Reports Earnings Results for the Third Quarter Ended September 30, 2018	15/18/15	CI
Dthera Sciences Appoints Amir Kalali to Board of Directors and Chairman of Scientific Advisory Board	30/18/30	CI
Dthera Sciences will Change its Ticker to DTHR.D from DTHR	25/18/25	CI
Dthera Sciences announced that it has received $1 million in funding from Ionic Ventures, LLC	21/18/21	CI
Dthera Sciences announced that it expects to receive $0.4 million in funding from RSJ Private Equity Uzavreny Investicni Fond a.s.	17/18/17	CI
Dthera Sciences announced that it expects to receive $0.25 million in funding from Wade Capital Corporation	14/18/14	CI
FDA Grants Breakthrough Device Designation to Dthera Sciences's DTHR-ALZ	23/18/23	CI
Dthera Sciences Launches ReminX	07/18/07	CI
Dthera Sciences announced that it has received $2.55125 million in funding	23/18/23	CI
Dthera Sciences Appoints Steve R. Martin as Director to the Board	14/18/14	CI
Dthera Sciences Reports Earnings Results for the Year Ended December 31, 2017	03/18/03	CI
Dthera Sciences announced a financing transaction	02/17/02	CI
CurePSP & Dthera Sciences Announces Initial Positive Results of Pilot Program	04/17/04	CI
Dthera Sciences announced that it has received $0.975 million in funding	21/17/21	CI
Dthera Sciences announced that it has received $0.09 million in funding	01/17/01	CI
Dthera Sciences announced a financing transaction	26/17/26	CI
Dthera Sciences announced that it expects to receive $0.975 million in funding	19/17/19	CI
Dthera Sciences announced that it has received $1.2439 million in funding	17/17/17	CI
Dthera Sciences will Change its Ticker to DTHR from KNMX.D	29/16/29	CI
Dthera Sciences Approves Fiscal Year Change from June 30 Year-End to Calendar Year-End of December 31	17/16/17	CI
Dthera Sciences announced that it expects to receive $1.2439 million in funding	17/16/17	CI
EveryStory, Inc. completed the acquisition of Knowledge Machine International, Inc. in a reverse merger transaction.	21/16/21	CI
EveryStory, Inc. entered into an acquisition and share Exchange agreement to acquire Knowledge Machine International, Inc. in a reverse merger transaction.	06/16/06	CI

Chart Dthera Sciences

Duration

Period

More charts

Company Profile

Dthera Sciences, formerly Knowledge Machine International, Inc., is a digital health company. The Company is focused on supporting Alzheimer's and Dementia patients catering to the senior living market. The Company offers a product, EveryStory. EveryStory uses a chat system (called Rachel) to directly engage with family members. Through EveryStory, users can send various photos and record audio. EveryStory is a closed system in which the people who are authorized to be within the residents group can add stories or audio.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+11.73%	226B
DANAHER CORPORATION	+9.53%	188B
INTUITIVE SURGICAL, INC.	+14.63%	137B
BOSTON SCIENTIFIC CORPORATION	+27.47%	108B
SIEMENS HEALTHINEERS AG	-0.04%	63.19B
EDWARDS LIFESCIENCES CORPORATION	+13.73%	52.26B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.86%	51B
AGILENT TECHNOLOGIES, INC.	+7.72%	43.89B
GE HEALTHCARE TECHNOLOGIES INC.	+7.86%	38.07B

Other Advanced Medical Equipment & Technology